April 6, 2012in Access to Medicines, European Union, Feature Post, IP, Patents, Pharmaceutical Drugs2by Editor866 Should Canada Strengthen IP Protection for Pharmaceutical Products? The European Union Thinks So... The Canadian government and European Union (EU) are currently negotiating a Comprehensive Economic and Trade Agreement (CETA). A key issue has been ensuring that Canadian intellectual property rights for pharmaceutical…
